These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 43981)

  • 1. MIF-I's differential actions as an opiate antagonist.
    Kastin AJ; Olson RD; Ehrensing RH; Berzas MC; Schally AV; Coy DH
    Pharmacol Biochem Behav; 1979 Dec; 11(6):721-3. PubMed ID: 43981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
    Zadina JE; Kastin AJ; Kersh D; Wyatt A
    Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone-like actions of MIF-1 do not require the presence of the pituitary.
    Kastin AJ; Nissen C; Zadina JE; Schally AV; Ehrensing RH
    Pharmacol Biochem Behav; 1980 Dec; 13(6):907-12. PubMed ID: 6111087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
    Gergen KA; Zadina JE; Kastin AJ; Paul D
    Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate receptor antagonism by L-prolyl-L-leucyl-glycinamide, MIF-I.
    Dickinson SL; Slater P
    Peptides; 1980; 1(4):293-9. PubMed ID: 6117839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
    Galina ZH; Kastin AJ
    Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
    Pillai NP; Bhargava HN
    Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of Tyr-MIF-1 and naloxone in two animal models involving benzodiazepine.
    Kastin AJ; Schwartzenburg D; Tsui L; Miller LG; Olson GA; Olson RD
    Brain Res Bull; 1989 Dec; 23(6):443-6. PubMed ID: 2575442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
    Erchegyi J; Kastin AJ; Zadina JE
    Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibitory effects of MIF-1, Tyr-MIF-1, naloxone and beta-funaltrexamine on body rotation-induced analgesia in the meadow vole, Microtus pennsylvanicus.
    Lipa SM; Kavaliers M; Ossenkopp KP
    Peptides; 1989; 10(3):493-7. PubMed ID: 2571138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
    Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
    Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIF-1 does not act like naloxone in antagonizing the cardiovascular activity of leucine-enkephalin in the conscious dog.
    Sander GE; Kastin AJ; Giles TD
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1301-3. PubMed ID: 6131437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone-like protective effect of MIF-1 (Pro-Leu-Gly-NH2) on hemorrhagic shock.
    Krause W; Nieber K; Ehrlich A; Bienert M; Oehme P
    Pharmazie; 1984 May; 39(5):352-3. PubMed ID: 6147863
    [No Abstract]   [Full Text] [Related]  

  • 18. Attenuation of morphine analgesia by alpha-MSH, MIF-I, melatonin and naloxone in the rat.
    Datta PC; Sandman CA; Hoehler FK
    Peptides; 1982; 3(3):433-7. PubMed ID: 6126866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of MIF-1 or naloxone to reverse ischemic-induced neurologic deficits in gerbils.
    Kastin AJ; Nissen C; Olson RD
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1083-5. PubMed ID: 6129645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyr-MIF-1, identified in brain tissue, and its analogs are active in two models of antinociception.
    Kastin AJ; Stephens E; Zadina JE; Coy DH; Fischman AJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):1045-9. PubMed ID: 2867563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.